Biogen (BIIB) Stock Coming Off Lows After Positive News About Alzheimer's Treatment

<p>Biogen (BIIB) is coming off lows after positive news regarding their new Alzheimer’s treatment drug, says George Tsilis. He talks about how BIIB has been upgraded to overweight Fromm equal weight at Wells Fargo. He also goes over how investors are not valuing royalty streams coming in properly from BIIB. He then demonstrates an example trade using BIIB. Tune in to find out more.</p><p><br></p>